CompaniesOrphan Technologies

Orphan Technologies

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

173

By Phase

NA: 1

By Status

UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
Today
NCT03625427
Hover over trial bars to see details

Recent Trials

NCT04226846Lead Sponsor
Feasibility Trial of the Bios Device for Continuous Glucose Monitoring
N/AUnknown
50 participants
Started: Dec 9, 2019 · Completed: Mar 15, 2020
NCT03625427Collaborator
Effect of Palmitoleic Acid on C-reactive Protein
NACompleted
123 participants
Started: Sep 26, 2019 · Completed: Nov 29, 2022
Related Companies
Travere Therapeutics (retrophin)
acquired
Orphan Technologies | Biotech Hunter | Biotech Hunter